SPX4,140.06-5.13 -0.12%
DIA328.42+0.45 0.14%
IXIC12,644.46-13.10 -0.10%

--UBS Adjusts Bristol-Myers Squibb Company Price Target to $75 From $73, Maintains Neutral Rating

--UBS Adjusts Bristol-Myers Squibb Company Price Target to $75 From $73, Maintains Neutral Rating

MT Newswires · 07/28/2022 07:32

Please log in to view news